1 Press Releases
N/A
TheraVitae Inc.’s (“TVI’s”) patent infringement legal action against RegenoCELL Therapeutics, Inc. (“RCLL”) advanced to its third hearing in December, 2011.By: Thomas Smeenk | 2011-12-12 | Intellectual Property